2 days Amgen: Strong Fundamentals But Expensive Valuation Justifies A Hold Seeking Alpha Amgen: Strong Fundamentals But Expensive Valuation Justifies A Hold. Amgen (AMGN) X
3 weeks Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge. Investor's Business Daily X
3 weeks Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen Investor's Business Daily X
1 month Amgen Inc. (AMGN) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Seeking Alpha X
1 month Wait for longer-term data with Amgen’s GLP-1, says Piper Sandler’s Christopher Raymond YouTube X
1 month Amgen Dives 5% Despite ‘Truly Remarkable’ Results For Obesity Treatment Investor's Business Daily X
1 month These Stocks Are Moving the Most Today: GM, Ford, Amgen, Eli Lilly, Super Micro, Best Buy, Analog Devices, Kohl’s, Semtech, and More Yahoo Finance X
2 months Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcare FXStreet X
2 months Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? Investor's Business Daily X